Supplemental Guarantor Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Millions	3 Months Ended												12 Months Ended
	Jan. 28, 2017	Oct. 29, 2016	Jul. 30, 2016	Apr. 30, 2016	Jan. 30, 2016	Oct. 31, 2015	Aug. 01, 2015	May 02, 2015	Jan. 31, 2015	Nov. 01, 2014	Aug. 02, 2014	May 03, 2014	Jan. 28, 2017	Jan. 30, 2016	Jan. 31, 2015
Net Cash Provided by (Used for) Operating Activities													$ 1,890	$ 1,869	$ 1,786
Investing Activities
Capital Expenditures													(990)	(727)	(715)
Proceeds from Sale of Other Assets, Investing Activities													53	196	0
Return of Capital													108	0	0
Payments to Acquire Businesses, Net of Cash Acquired													(33)	0	0
Proceeds from Sale of Equity Method Investments													0	85	0
Payments to Acquire Marketable Securities													0	(60)	0
Proceeds from Sale and Maturity of Marketable Securities													10	50	0
Other Investing Activities													19	13	16
Net Cash Provided by (Used for) Investing Activities													(833)	(443)	(699)
Proceeds from Debt, Net of Issuance Costs													692	988	0
Financing Activities
Borrowings from Debt Facilities													35	7	5
Repayments of Lines of Credit													(6)	0	(5)
Payments of Dividends	$ (172)	$ (173)	$ (173)	$ (750)	$ (145)	$ (146)	$ (146)	$ (734)	$ (100)	$ (100)	$ (99)	$ (392)	(1,268)	(1,171)	(691)
Repurchases of Common Stock													(435)	(483)	(87)
Excess Tax Benefits from Share-based Compensation													42	70	43
Net Financing Activities and Advances to/from Consolidated Affiliates													0	0	0
Proceeds from Stock Options Exercised													20	33	35
Proceeds from (Payments for) Other Financing Activities													(3)	(2)	(6)
Net Cash Provided by (Used for) Financing Activities													(1,665)	(558)	(919)
Effects of Exchange Rate Changes on Cash													(6)	(1)	(6)
Net Increase (Decrease) in Cash and Cash Equivalents													(614)	867	162
Cash and Cash Equivalents, Beginning of Year				2,548				1,681				1,519	2,548	1,681	1,519
Cash and Cash Equivalents, End of Year	1,934				2,548				1,681				1,934	2,548	1,681
Repayments of Long-term Debt													(742)	0	(213)
Eliminations
Net Cash Provided by (Used for) Operating Activities													0	0	0
Investing Activities
Capital Expenditures													0	0	0
Proceeds from Sale of Other Assets, Investing Activities													0	0
Return of Capital													0
Payments to Acquire Businesses, Net of Cash Acquired													0
Proceeds from Sale of Equity Method Investments														0
Payments to Acquire Marketable Securities														0
Proceeds from Sale and Maturity of Marketable Securities													0	0
Other Investing Activities													0	0	0
Net Cash Provided by (Used for) Investing Activities													0	0	0
Proceeds from Debt, Net of Issuance Costs													0	0
Financing Activities
Borrowings from Debt Facilities													0	0	0
Repayments of Lines of Credit													0		0
Payments of Dividends													0	0	0
Repurchases of Common Stock													0	0	0
Excess Tax Benefits from Share-based Compensation													0	0	0
Net Financing Activities and Advances to/from Consolidated Affiliates													0	0	0
Proceeds from Stock Options Exercised													0	0	0
Proceeds from (Payments for) Other Financing Activities													0	0	0
Net Cash Provided by (Used for) Financing Activities													0	0	0
Effects of Exchange Rate Changes on Cash													0	0	0
Net Increase (Decrease) in Cash and Cash Equivalents													0	0	0
Cash and Cash Equivalents, Beginning of Year				0				0				0	0	0	0
Cash and Cash Equivalents, End of Year	0				0				0				0	0	0
Repayments of Long-term Debt													0		0
L Brands, Inc. [Member]
Net Cash Provided by (Used for) Operating Activities													(462)	(322)	(333)
Investing Activities
Capital Expenditures													0	0	0
Proceeds from Sale of Other Assets, Investing Activities													0	0
Return of Capital													0
Payments to Acquire Businesses, Net of Cash Acquired													0
Proceeds from Sale of Equity Method Investments														0
Payments to Acquire Marketable Securities														0
Proceeds from Sale and Maturity of Marketable Securities													0	0
Other Investing Activities													0	0	0
Net Cash Provided by (Used for) Investing Activities													0	0	0
Proceeds from Debt, Net of Issuance Costs													692	988
Financing Activities
Borrowings from Debt Facilities													0	0	0
Repayments of Lines of Credit													0		0
Payments of Dividends													(1,268)	(1,171)	(691)
Repurchases of Common Stock													(435)	(483)	(87)
Excess Tax Benefits from Share-based Compensation													0	0	0
Net Financing Activities and Advances to/from Consolidated Affiliates													2,195	955	1,295
Proceeds from Stock Options Exercised													20	33	35
Proceeds from (Payments for) Other Financing Activities													0	0	(6)
Net Cash Provided by (Used for) Financing Activities													462	322	333
Effects of Exchange Rate Changes on Cash													0	0	0
Net Increase (Decrease) in Cash and Cash Equivalents													0	0	0
Cash and Cash Equivalents, Beginning of Year				0				0				0	0	0	0
Cash and Cash Equivalents, End of Year	0				0				0				0	0	0
Repayments of Long-term Debt													(742)		(213)
Guarantor Subsidiaries
Net Cash Provided by (Used for) Operating Activities													1,848	1,835	1,677
Investing Activities
Capital Expenditures													(705)	(506)	(486)
Proceeds from Sale of Other Assets, Investing Activities													0	0
Return of Capital													0
Payments to Acquire Businesses, Net of Cash Acquired													0
Proceeds from Sale of Equity Method Investments														1
Payments to Acquire Marketable Securities														(50)
Proceeds from Sale and Maturity of Marketable Securities													0	50
Other Investing Activities													(2)	0	(1)
Net Cash Provided by (Used for) Investing Activities													(707)	(505)	(487)
Proceeds from Debt, Net of Issuance Costs													0	0
Financing Activities
Borrowings from Debt Facilities													0	0	0
Repayments of Lines of Credit													0		0
Payments of Dividends													0	0	0
Repurchases of Common Stock													0	0	0
Excess Tax Benefits from Share-based Compensation													37	62	37
Net Financing Activities and Advances to/from Consolidated Affiliates													(1,803)	(662)	(1,118)
Proceeds from Stock Options Exercised													0	0	0
Proceeds from (Payments for) Other Financing Activities													(3)	(2)	0
Net Cash Provided by (Used for) Financing Activities													(1,769)	(602)	(1,081)
Effects of Exchange Rate Changes on Cash													0	0	0
Net Increase (Decrease) in Cash and Cash Equivalents													(628)	728	109
Cash and Cash Equivalents, Beginning of Year				2,190				1,462				1,353	2,190	1,462	1,353
Cash and Cash Equivalents, End of Year	1,562				2,190				1,462				1,562	2,190	1,462
Repayments of Long-term Debt													0		0
Non-Guarantor Subsidiaries
Net Cash Provided by (Used for) Operating Activities													504	356	442
Investing Activities
Capital Expenditures													(285)	(221)	(229)
Proceeds from Sale of Other Assets, Investing Activities													53	196
Return of Capital													108
Payments to Acquire Businesses, Net of Cash Acquired													(33)
Proceeds from Sale of Equity Method Investments														84
Payments to Acquire Marketable Securities														(10)
Proceeds from Sale and Maturity of Marketable Securities													10	0
Other Investing Activities													21	13	17
Net Cash Provided by (Used for) Investing Activities													(126)	62	(212)
Proceeds from Debt, Net of Issuance Costs													0	0
Financing Activities
Borrowings from Debt Facilities													35	7	5
Repayments of Lines of Credit													(6)		(5)
Payments of Dividends													0	0	0
Repurchases of Common Stock													0	0	0
Excess Tax Benefits from Share-based Compensation													5	8	6
Net Financing Activities and Advances to/from Consolidated Affiliates													(392)	(293)	(177)
Proceeds from Stock Options Exercised													0	0	0
Proceeds from (Payments for) Other Financing Activities													0	0	0
Net Cash Provided by (Used for) Financing Activities													(358)	(278)	(171)
Effects of Exchange Rate Changes on Cash													(6)	(1)	(6)
Net Increase (Decrease) in Cash and Cash Equivalents													14	139	53
Cash and Cash Equivalents, Beginning of Year				$ 358				$ 219				$ 166	358	219	166
Cash and Cash Equivalents, End of Year	$ 372				$ 358				$ 219				372	$ 358	219
Repayments of Long-term Debt													$ 0		$ 0